IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q1 FY23 results · Apr–Jun 2022
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹565.01 crore and net profit of ₹34.67 crore for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 565.01 | — | — | 572.49 | −1.3% |
| Other income | 5.16 | — | — | 6.93 | −25.5% |
| Total income | 570.17 | — | — | 579.42 | −1.6% |
| Profit before tax | 46.59 | — | — | 38.71 | +20.4% |
| Net profit for the period | 34.67 | — | — | 29.76 | +16.5% |
| EPS, basic (₹) | 5.91 | — | — | 5.07 | +16.6% |
| Net margin (%) | 6.1 | — | 5.2 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 565.01 | 518.51 | +9.0% | 572.49 | −1.3% |
| Other income | 5.15 | 5.72 | −10.0% | 6.93 | −25.7% |
| Total income | 570.16 | 524.23 | +8.8% | 579.42 | −1.6% |
| Profit before tax | 46.81 | 89.85 | −47.9% | 36.70 | +27.5% |
| Net profit for the period | 34.89 | 67.00 | −47.9% | 27.75 | +25.7% |
| EPS, basic (₹) | 5.94 | 11.41 | −47.9% | 4.73 | +25.6% |
| Net margin (%) | 6.2 | 12.9 | 4.8 |
Consolidated
- Filed with BSE
- 10 Aug 2022, 18:45 IST
- Board meeting
- 09 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Aug 2022, 18:45 IST
- Board meeting
- 09 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Audited
- Source
- XBRL filing on BSE